Adalimumab (Humira®) Induced Recurrent Peritonsillar Abscess in A Patient Received Three Different Anti-TNF Therapies: A Case Report

Anti-tumor necrosis factor agents are widely used in treating ankylosing spondylitis, but they increase the risk of infection by suppressing the immune response. Therefore, physicians should be careful about recurrent infections in patients under anti-tumor necrosis factor agents.

Detalles Bibliográficos
Autores principales: Vural, Sevilay, Kuşdoğan, Mikail, Kaya, Hasan Burak, İkiz, Venhar, Albayrak, Levent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer India 2022
Materias:
Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235369/
https://www.ncbi.nlm.nih.gov/pubmed/37274971
http://dx.doi.org/10.1007/s12070-022-03203-0
Descripción
Sumario:Anti-tumor necrosis factor agents are widely used in treating ankylosing spondylitis, but they increase the risk of infection by suppressing the immune response. Therefore, physicians should be careful about recurrent infections in patients under anti-tumor necrosis factor agents.

Ejemplares similares